Compare Agilent Technologies Inc (A) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agilent Technologies Inc vs Invesco NASDAQ 100 ETF — how do they compare? Agilent Technologies Inc trades at $148.88 (market cap $42.22B), while Invesco NASDAQ 100 ETF trades at $297.67. The key difference: Agilent Technologies Inc pays a 0.68% dividend while Invesco NASDAQ 100 ETF pays none. Which is the better fit depends on your goals.
| A | QQQM | |
|---|---|---|
Market Cap | $42.22B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $157.20 | $307.23 |
52-Week Low | $110.24 | $229.87 |
Enterprise Value | $43.77B | — |
Dividend Yield | 0.68% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $148.72, up 1.88% with strong analyst support (77.5% buy ratings). The stock shows bullish technical momentum above key support levels, supported by consistent revenue around $6.9B and robust profitability with 19.55% net margins. Recent FDA approvals for diagnostic tests and the Biocare Medical acquisition enhance growth prospects in biopharma markets.
Outlook remains positive with a $154.90 consensus price target offering 4% upside, though high P/E of 30.02 poses valuation risk. Key catalysts include Q2 2026 earnings due August 26 and AI-driven lab expansion, while overbought RSI levels near 92 suggest near-term consolidation potential.
QQQM trades at $298.50, up 0.58% with a bullish technical outlook supported by moving averages. The ETF tracks the Nasdaq-100 index with exposure to large-cap tech stocks. Recent news highlights QQQM's lower expense ratio advantage over QQQ at $15 annually versus $18, making it an attractive cost-efficient option for Nasdaq-100 exposure. The fund has demonstrated strong historical performance with approximately 14% average annual returns since inception.
The outlook remains positive given Nasdaq's tech-led rally potential in H2 2026, though investors face concentration risk in mega-cap tech holdings. Key risks include market volatility and potential regulatory scrutiny of large tech companies. QQQM offers efficient Nasdaq-100 exposure with competitive fees for long-term growth investors seeking tech sector leadership.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agilent Technologies Inc
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →About Invesco NASDAQ 100 ETF
QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →
